Filter
2795
Filtered Results: 2795
Text search:
medical-therapeutic
Featured
Recommendations
330
New Publications
659
Language
Document type
No document type
1479
Guidelines
510
Studies & Reports
432
Manuals
159
Strategic & Response Plan
88
Fact sheets
44
Training Material
42
Situation Updates
24
Brochures
6
Resource Platforms
6
Infographics
4
Online Courses
1
Countries / Regions
India
135
Global
87
South Africa
81
Kenya
79
Ethiopia
65
Western and Central Europe
58
Sierra Leone
51
Uganda
51
Nepal
43
Nigeria
40
Africa
37
Liberia
35
Ghana
33
Latin America and the Carribbean
33
Rwanda
32
Tanzania
32
Zambia
32
Germany
31
Brazil
31
Mozambique
30
Congo, Democratic Republic of
29
Bangladesh
25
Malawi
24
Zimbabwe
24
Namibia
24
Myanmar / Burma
23
Philippines
21
Russia
19
West and Central Africa
17
Ukraine
16
Haiti
16
South Sudan
16
Syria
15
Burkina Faso
15
South–East Asia Region
15
Paraguay
15
Argentina
15
Eastern Europe
15
Indonesia
15
Lesotho
14
East and Southern Africa
14
Senegal
13
Middle East and North Africa
13
Colombia
12
Cambodia
12
Guinea
11
Eswatini/ Swaziland
11
Cameroon
10
Benin
8
Asia
8
Eastern Europe and Central Asia
8
Angola
8
Pakistan
8
Chile
7
USA
7
Venezuela
7
Yemen
7
Botswana
7
Bolivia
6
Vietnam
6
Guinea-Bissau
5
Sudan
5
Central African Republic
5
Mali
5
Iraq
5
Tajikistan
4
Thailand
4
El Salvador
4
Laos
4
Burundi
4
Peru
4
Western Pacific Region
4
United Kingdom
4
Spain
4
North Macedonia
3
China
3
Fiji
3
Afghanistan
3
Jordan
3
Poland
3
Bhutan
3
Ecuador
3
Serbia
2
Iran
2
Albania
2
Singapore
2
Estonia
2
Uzbekistan
2
Armenia
2
Lithuania
2
Gabon
2
Mauritius
2
Portugal
2
Southern Africa
2
Moldova
2
Sri Lanka
2
Romania
2
Georgia
2
Chad
2
Libya
2
Switzerland
1
Mexico
1
Turkey
1
Australia
1
Gambia
1
Kazakhstan
1
Canada
1
Kyrgyzstan
1
Niger
1
Malaysia
1
Mongolia
1
Bulgaria
1
Italy
1
Hungary
1
Ireland
1
Saudi Arabia
1
North America
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Belarus
1
Papua New Guinea
1
Egypt
1
Somalia
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
1090
Clinical Guidelines
283
Public Health
136
Women & Child Health
132
Key Resources
95
Pharmacy & Technologies
34
Capacity Building
29
Annual Report MEDBOX
2
Toolboxes
Mental Health
333
COVID-19
275
AMR
180
Pharmacy
142
HIV
139
TB
119
Caregiver
83
NTDs
82
Ebola
74
NCDs
73
Rapid Response
72
Disability
58
Conflict
55
Refugee
48
Planetary Health
29
Natural Hazards
26
Global Health Education
20
Health Financing Toolbox
16
Social Ethics
13
Specific Hazards
11
Cholera
11
Zika
11
Polio
8
South Sudan
1
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of information concerning the chronic phase of human Chaga...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r...
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 117: e200460, 2022
Integrating the multiple dimensions of the problem into a coherent approach adapted to field realities and needs represents an immense challenge, but the payoff is more effective and sustainable experiences, with higher social awareness...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was form...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was...
Leishmaniasis is a climate-sensitive disease. Changes in temperature, rainfall, and humidity can have strong impacts on
the sandfly vector, altering their distribution and influencing their survival and population sizes. Increased temperatures shorten vector development time, reduce Leishmania para...
The Onchocerciasis Control Programme in West Africa (OCP) undertook regional and large scale frght against onchocerciasis in West Africa in 1974 using a vector control strategy. By 2002 OCP had succeeded in eliminating the disease as a public health, socio-economic and development problem in 10 out ...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
The objectives of the meeting were:
1. To step up the commitment of national authorities and technical and financial partners toWHO’s elimination objective for g-HAT.
2. To share achievements, challenges and views on the elimination goal among countries and implementing partners.
3. To assess t...
The objectives of the meeting were:
1. To update the current status of the disease transmission, country capacities and plans for tackling the disease.
2. To understand the epidemiology including disease distribution and risk, the models
for estimating under-detection, the geographical variati...
The Pharmaceutical Forum of the Americas (PFA) has previously published guidelines and organised campaigns for community pharmacists on the prevention, detection and control of arbovirus infections in 2018 with a grant from the FIP Foundation for Pharmacy Education and Research. Building on that exp...
The World Health Organization Regional Office for Africa (WHO AFRO), in accordance with recommendations from various WHO committees, has developed three flagship initiatives to support Member States in the African region to prepare for, detect and respond to public health emergencies. They are the r...
Following the publication of Guidelines on certification of elimination of human onchocerciasis in 2001 by the World Health Organization (WHO), these are the first evidence-based guidelines developed by NTD Department according to the international standards. They provide a set of recommendations th...
The Transformation Agenda (TA) ushered in an ambitious reform process intended to transform the World Health Organization (WHO) into an organization that is proactive, results-driven, accountable and which meets stakeholder expectations, towards transforming and improving public health services in t...
This document is an output of a WHO cross-programme initiative aiming to improve the prevention, diagnosis and management of anaemia and thereby accelerate reduction in its prevalence. It comes at an important time, midway through the era of the Sustainable Development Goals, when progress in reduci...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
The Regional Action Framework for Noncommunicable Disease Prevention and Control provides a unified vision of objectives and recommended actions to combat the noncommunicable disease (NCD) epidemic in the Western Pacific Region. Implementation should be supported by cross-sectoral coordination...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
